Read about our patients and how unique St. Jude research programs help them not just survive, but lead happier, healthier adult lives.
St. Jude believes survivorship begins the day of diagnosis. Learn more about how our doctors and research programs are helping our patients and cancer survivors around the world.
-
Hodgkin Lymphoma: When Lightning Strikes Twice
Why are some families struck with multiple cases of Hodgkin lymphoma? Learn about the FAMHL clinical trial designed to pinpoint genetic causes.
-
Immunotherapy: Power from Within
A promising new therapy mobilizes a child’s immune system to help kill cancer cells.
-
St. Jude Biorepository: A Hope Chest of Cells
St. Jude patients donate tissue to the biorepository in hopes that their preserved biological samples will be used in groundbreaking cancer research.
-
Six More Reasons to Love St. Jude
Patients and families often praise St. Jude clinical care and research. Find out why they have even more reasons to love the hospital.
-
Medulloblastoma: The Pieces Snap Together
St. Jude scientists discover genes suspected to cause brain tumors in children. This discovery lays the foundation to expand targeted treatments.
-
SJFAMILY: Shaking the Family Tree
Through the SJFAMILY study, St. Jude investigators explore why some cancers run in families and why certain people get more than one cancer.
-
Life after Cancer Treatment: Incorrigible Optimism
A cancer survivor explains why he participates in SJLIFE — a long-term follow-up study to assess late effects of treatments. It’s not “Would I?” It’s “Why wouldn’t I?”
-
School Liaison Services Help Kids Go Back to School after Treatment
It takes preparation to make a seamless transition back to the classroom. Find out how St. Jude school liaisons help ease children back into their community schools.
-
Life After Treatment: My Legacy
A long-term cancer survivor shares his story of St. Jude, how cancer shaped his life, and what his life is like after remission.
Resources for Survivors
After our patients have successfully completed their cancer treatment at St. Jude, we are still part of their journey. Our goal is to help all childhood cancer survivors live long and healthy lives. We offer unique follow-up programs and tips for survivors.
Improved treatments and long-term care for pediatric cancer patients are changing the landscape of cancer survivorship. St. Jude is pioneering the field with major research programs that follow thousands of survivors for decades after their treatment.
Latest Survivorship Research
-
Promoting HPV vaccination among childhood cancer survivors
The St. Jude Transition Oncology Program and the HPV Cancer Prevention Program are working together to promote HPV vaccination for childhood cancer survivors.
-
It’s in the genes: research reveals obstacles on the road to health for cancer survivors
St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.
-
Pain may be a risk factor for learning problems in childhood cancer survivors
Researchers are focusing on treatment-related pain as another way to reduce the risk of learning and memory problems in survivors of childhood leukemia.
-
Identifying risks and restrictions: Rehabilitation and cancer survivorship
Finally, there is a comprehensive overview of rehab screenings and assessments for pediatric cancer patients and survivors.
-
For the growing number of childhood cancer survivors, five-year survival is just the beginning
As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.
-
Unraveling the ambiguity of risk for childhood cancer survivors
Clinical specialists are learning this about the future for childhood cancer survivors and how to help them.
-
Health inequity may drive higher symptom burden in childhood cancer survivors
Findings from St. Jude Children’s Research Hospital reveal that childhood cancer survivors with disadvantaged socio-demographic factors are over 7 times more likely to experience severe symptom burdens.
-
Genetics weigh heavy on childhood cancer survivors’ risk of developing obesity
St. Jude scientists created a way to identify childhood cancer patients at diagnosis who are at the highest risk for developing severe obesity as adults.
-
A high-risk pair – a drug and DNA variant increase heart disease risk in cancer survivors
St. Jude scientists identified a genetic difference in childhood cancer survivors treated with chemotherapy that predisposes them to heart problems as adults.
-
Chronologically young, biologically old – DNA linked to cancer survivors’ premature aging
St. Jude Children’s Research Hospital findings lay the groundwork for identifying pediatric cancer survivors at higher risk of accelerated aging and chronic diseases.